The Vigilance and Benefit- Risk Assessment Executive Directorate  is responsible for all activities related to pre- and post marketing assessment of safety and efficacy of registered products.
The Executive Directorate is divided into three main departments:
1- National Pharmacovigilance and Drug Safety Center (NPC).
2- Benefit- Risk Assessment Department (BRAD).
3- Medication Errors Department.